Biochemistry Seminar: Pranam Chatterjee, "Designing Programmable Biologics with Generative Sequence Models"

Dates
Wed, Sep 02, 2026 - 12:00 PM — Wed, Sep 02, 2026 - 01:00 PM
Admission Fee
Free. Refreshments will be available in the ASRC Cafe at 11:30 AM.
Event Address
This speaker will be in-person at the ASRC Main Auditorium, 85 Saint Nicholas Terrace.
Phone Number
212-650-8803
Event Location
This seminar will also be available by Zoom. Zoom link: https://gc-cuny.zoom.us/j/96975997619?pwd=C4JXA4s7H3L4sgnmmpWmoHdCunxLbe.1
Meeting ID: 969 7599 7619. Passcode: asrc**ccny. Full names must be used to be admitted.
Event Details

Pranam Chatterjee, Assistant Professor of Bioengineering; Computer & Information Science, University of Pennsylvania School of Engineering, will give a talk on "Designing Programmable Biologics with Generative Sequence Models."

This seminar will also be available by Zoom. Zoom link: https://gc-cuny.zoom.us/j/96975997619?pwd=C4JXA4s7H3L4sgnmmpWmoHdCunxLbe.1 Meeting ID: 969 7599 7619. Passcode: asrc**ccny

Please note: 

  • Full names must be used to be admitted to the Zoom meeting.
  • The Zoom meeting will be closed and locked at 12:15 p.m., and no one will be able to enter the meeting after that time.

ABSTRACT

In this talk, I will share how my lab develops discrete generative models to design functional biologics for disease and bioremediation. Our work has centered on language models that de novo design peptides to bind and modulate undruggable targets, with experimental validation across rare neurodegenerative disorders, pediatric cancers, and viral infections. Because therapeutic design depends on clinically-viable properties beyond binding (solubility, half-life, non-toxicity), we have developed discrete diffusion algorithms to generate peptides, proteins, mRNAs, and heavy metal sequestrants that are Pareto-optimal across these properties. We have extended these frameworks to discrete flow matching models that generate isoform-specific, domain- and motif-resolved binders under competing therapeutic objectives, enabling the design of potent inhibitors and CAR T cell ligands. Finally, we have recently pioneered Schrödinger Bridge Matching, a new class of generative models that capture both biological states and the trajectories connecting them, from protein folding to drug-induced cell-state transitions, establishing a unified, programmable framework for molecular modeling and design.

Note

Please Note: All public events must comply with the Public Event Code of Conduct

Back to Departmental Calendar Back to calendar of events